Related Experiment Videos
[Cytogenetics in pediatric solid tumors]
1Department of Laboratory Medicine, Saitama Cancer Center.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 1, 1990
Summary
Chromosome abnormalities like deletions and translocations are key in pediatric solid tumors. Genetic analysis aids diagnosis and prognosis for conditions like retinoblastoma and neuroblastoma.
Area of Science:
- Cytogenetics and molecular genetics
- Cancer biology
- Pediatric oncology
Context:
- Pediatric solid tumors exhibit diverse chromosomal abnormalities, including deletions, translocations, homogeneously staining regions (hsr)/double minutes (dms), and ploidy alterations.
- Specific deletions, such as 13q14 in retinoblastoma and 11p13 in Wilms' tumor, have led to the identification of critical cancer genes.
- Translocations are frequently observed in soft tissue sarcomas, aiding in diagnosis and treatment selection.
Purpose:
- To highlight the significance of chromosomal abnormalities in pediatric solid tumors.
- To underscore the role of genetic alterations in tumor development and progression.
- To emphasize the diagnostic and prognostic value of cytogenetic and molecular analyses.
Summary:
- Chromosome abnormalities, including deletions and translocations, are common in pediatric solid tumors.
- Specific genetic alterations, like N-myc amplification in neuroblastoma, correlate with tumor stage and prognosis.
- Cytogenetic and molecular analyses are crucial for accurate diagnosis and predicting patient outcomes.
Impact:
- Advances in understanding pediatric cancer genetics.
- Improved diagnostic accuracy for rare and complex tumors.
- Enhanced prognostic prediction, guiding personalized treatment strategies.